CD4 and angina pectoris: When stratifying unstable angina patients by CD4+CD28null T-cell expansion status, Liuzzo et al. found that patients with an expansion (>10% of total T cells) saw almost half the number of cardiovascular events after 2 years if they were on statins than if they were not.